1. Introduction {#s0005}
===============

Around 3.2 million adults in Great Britain currently use an EC ([@b0010]). The most commonly cited reason for use is to reduce or quit smoking ([@b0010], [@b0140]) and there is increasing evidence for their effectiveness for smoking cessation ([@b0065], [@b0075]). E-cigarettes (EC) can be considered as tobacco harm reduction products as evidence suggests that they are considerably less harmful than tobacco cigarettes ([@b0020], [@b0055], [@b0060], [@b0070], [@b0115], [@b0155], [@b0160], [@b0165]). It is estimated that EC carry approximately 5% of the health risk associated with tobacco smoking ([@b0125], [@b0120], [@b0150]). Public health bodies and policy-makers (in the UK) recommend that smokers who are unwilling or unable to quit should be encouraged to switch to EC ([@b0125], [@b0120], [@b0150]). However, misperceptions of harm continue to increase. In Great Britain only 13% of survey respondents correctly believed that EC are considerably less harmful than tobacco smoking ([@b0005]) while in a sample of 4058 Greek residents, 5% perceived EC to be less harmful than cigarettes ([@b0050]). A recent longitudinal survey (N = 1720 UK current and former smokers) showed that just under half of respondents overestimated the harms of EC with 57.3% perceiving EC as less harmful than smoking ([@b0180]). These misperceptions were more prevalent in smokers who had never tried vaping suggesting that inaccurate information might be a contributing factor in deterring smokers from trying ECs ([@b0180]). To the extent that there is a need to redress these misperceptions, messages which communicate the relative risks of vaping compared to smoking may be of utility.

Warning labels, as used on tobacco products, have been the cornerstone of a comprehensive tobacco control plan aimed at both deterring non-smokers from trying the products whilst communicating the risks of smoking to smokers. How best to communicate risks of vaping (to deter non-smokers) while seeking to attract smokers to switch to a less harmful product, remains an ongoing question. Current messages on EC packaging present a standardised addiction health warning covering 30% of the pack. Article 20 of the EU Tobacco Products Directive \[TPD\] ([@b0040]) requires that EC packets and refill products carry a health warning stating, either: i) '*This product contains nicotine which is a highly addictive substance*', or ii) '*This product contains nicotine which is a highly addictive substance. It is not recommended for use by non-smokers*'. Given current misperceptions and concerns around addiction per se, warning messages which focus solely on the potential of EC to lead or maintain addiction may maintain public misperceptions of the harms of EC and discourage use amongst smokers. Indeed, concerns over substituting one addiction for another is the most commonly cited reason in deterring *never vaped* smokers from EC use ([@b0005]).

To date, research exploring the impact of EC health warnings has been conducted outside of Europe, thus potential effects of the mandatory TPD nicotine addiction warning messages are underexplored. Experimental work has shown that exposure to EC advertisements ([@b0015]) and EC health warnings conveying health and addiction risks, led to increased harm and addictiveness perceptions and decreased use intentions in smokers, EC users ([@b0015]), and young non-smokers ([@b0030], [@b0105]). However, these effects are not equivocal (e.g. see [@b0105], [@b0170]). Because current TPD messages focus on the absolute risks of nicotine use, they may actually deter use in smokers and undermine the potential of EC to assist a change in smoking behaviour. Whilst reducing appeal amongst non-smokers is clearly desirable, effective health messaging should communicate risks without discouraging smokers. Comparative health messages, which focus on the reduced risks of EC in relation to tobacco smoking, may provide a viable alternative and/or complement to the EU-TPD messages, and increase the perceived utility and value of using EC as a quit aid.

1.1. Aims {#s0010}
---------

This study aimed to investigate the effects of the EU-TPD EC health warnings and a comparative harm message (COMP) on smokers' and non-smokers' perceptions of harm, addictiveness, effectiveness and social acceptability of EC. We also aimed to explore the effects of the EU-TPD warnings on smokers' and non-smokers' intentions to purchase and use an EC, and on smokers' quit intentions and intentions to use EC in future quit attempts. Lastly, the potential effects of providing a comparative harm message either in addition to the TPD warning or as a stand-alone message were also explored.

2. Method {#s0015}
=========

2.1. Design {#s0020}
-----------

Ethical approval was granted by the School of Applied Sciences Ethics Committee at London South Bank University (4/07/2018; reference SAS1815). Data were collected in the UK between December 2018 and January 2019. A 2 × 2 × 2 × 2 factorial design with Smoking status (Smoker vs. Non-smoker), TPD presence (Presence vs. Absence) and COMP presence (Presence vs. Absence) as between-subject factors, and Time (pre-post exposure of images/health messages) as a within-subjects factor. Dependent variables comprised self-reported perceived harm, addictiveness, social acceptability, effectiveness, intentions to purchase and use of EC, intentions to quit and intentions to use ECs in future quit attempts.

2.2. Participants {#s0025}
-----------------

2495 UK residents were recruited (N = 1283 smokers; N = 1212 non-smokers; see [@b0085] for sample size calculation). Participants were enrolled via a recruitment panel agency MRFGR (Market Research Focus Group Recruiter). Remuneration was on a point-based system, each participant received 6 points (a minimum of 150 points can be redeemed via PenPal, Amazon gift cards, lottery tickets and charity donations). The sample was matched to the target population of smokers' demographics in the general population using ONS data concerning age, gender and socio-economic status (SES). The same sampling stratification was applied to non-smokers. Inclusion criteria were: adults aged 18+, resident in the UK, and fluent in English. Exclusion criteria were: under 18 years of age, resident outside of the UK, exclusive vapers, dual users (concurrent use of EC and any tobacco product).

2.3. Materials and measures {#s0030}
---------------------------

### 2.3.1. Measures {#s0035}

All measures were completed online. Demographic variables included gender, age, ethnicity, occupation, and highest attained qualification in line with data collected by the Office for National Statistics (ONS) and others (e.g. [@b0185]).

Participants were classified as 'non-smoker', 'daily smoker' and 'occasional smoker' (see [@b0085] for full definitions). As per our published protocol ([@b0085]), daily and occasional smokers were combined so analyses included a binary measure of smoking status (Smoker vs. non-smoker).

For smokers, motivation to quit was measured using the Motivation to Stop Scale (\[MTSS\] ([@b0090])). Cigarette dependence was measured using the Fagerström Test for Cigarette Dependence (FTCD) ([@b0045]).

The COMP message was generated in a pilot study (which gathered ratings on how clear, understandable and believable a range of relative risk health messages were) and selected for its higher than average overall mean rating and its brevity (see [@b0085] for further details on the conceptualisation of the message). Each message was placed on a series of 4 different types of EC packs (see [Fig. 1 in supplementary materials](#s0130){ref-type="sec"}) for a standardised period of 30 s. In line with the current EU-TPD requirements all messages occupied 30% of the surface of the pack and were presented in black Helvetica bold type on a white background.

Prior to, and following the experimental exposure to one of the EC health messages (see [Table 1](#t0005){ref-type="table"}), perceptions of EC and intentions were measured on the following scales: i) harmfulness, ii) addictiveness and ii) socially acceptable, iv) effectiveness as a cessation aid, v) intention to use, vi) intention to purchase and, for smokers only, vii) intentions to quit and use e-cigarettes in a future quit attempt (all on a 7-point rating scales anchored at "Extremely", to "Not at all"; see [@b0085] for the full list of constructs). To minimise response bias, unrelated questions (e.g. "*Which e-cigarette did you think looked most like a cigarette?*") were presented following exposure of the message stimuli in addition to outcome measures.Table 1Stimuli parameters and statements used in each condition.ConditionsParametersMessage statementsTPD1TPD health warning as per currently implemented in the UK"*This product contains nicotine which is a highly addictive substance*"TPD2TPD longer health warning as currently implemented in many EU countries"*This product contains nicotine which is a highly addictive substance. It is not recommended for non-smokers*"COMPSame parameters used for the TPD warning labels; font, font colour, size and placement on the pack"*Use of this product is much less harmful than smoking*"TPD1+The TPD health warning (TPD1) in combination with the comparative message (using the same parameters above)"*This product contains nicotine which is a highly addictive substance. Use of this product is much less harmful than smoking"*TPD2+The TPD longer health warning (TPD2) in combination with the comparative message (using the same parameters as above)*"This product contains nicotine which is a highly addictive substance. It is not recommended for non-smokers. Use of this product is much less harmful than smoking"No message*A *no message* condition using the same EC pack images

### 2.3.2. Procedure {#s0040}

The full procedure is outlined in our protocol paper ([@b0085]). Upon providing online consent, demographic data were collected and followed by the FTCD and MTSS questionnaires (smokers only). All participants were then asked about their perceived harm, addictiveness, social acceptability, effectiveness, intentions to purchase and use of EC. Smokers were also asked about their intentions to quit and intentions to use ECs in future quit attempts. Each participant was randomised to one of the six messages on EC pack images (see [Table 1](#t0005){ref-type="table"}) and viewed sequentially; four EC packs containing one of the messages (or no message for the control group) each for 30 s. Following exposure of the stimuli, filler questions and outcome measures were completed. Finally, participants were debriefed.

### 2.3.3. Data analysis {#s0045}

As per our published protocol, a series of ANCOVAs were conducted with 3 between-factors: Smoking Status (Smoker vs. Non-smoker), TPD Presence (Present vs. Absent), COMP Presence (Present vs. Absent) with DVs consisting of Time 2 perceived ratings of EC i) harm, ii) addictiveness, iii) social acceptability, iv) effectiveness, v) intention to quit, vi) intention to purchase and vii) intention to use ECs to observe the main effects and interactions whilst controlling for Time 1 measurements of the DV. All main and interactive simple effects were tested, with planned a-priori comparisons between the TPD alone condition against i) TPD + COMP, ii) no TPD/no COMP iii) no TPD/COMP, and the COMP alone condition against i) TPD + COMP, ii) no TPD/no COMP, iii) TPD/no COMP. These were conducted at each level of smoking status. As per protocol, for secondary analyses, the same ANCOVAs were repeated i) controlling for cigarette dependence, previous e-cigarette exposure, and baseline intentions to quit and, ii) exploring the interactions with demographic variables (age, sex and occupation). For i) only significant main effects and interactions are reported here and for ii) adding demographics co-variates did not change the overall pattern of main effects and interactions reported here; these results will be reported separately and made available via the Open Science Framework: osf.io/ta4vx. As per our published protocol, outliers were calculated (±2.5 SD) for each variable before removal, the total numbers discarded differed per variable and ranged between 15 and 69. When outliers were included the effects of the COMP vs. no message on smokers' harm perceptions and the effect of the TPD vs. no message on smokers' perceptions of EC addictiveness fell short of statistical significance. In addition, a further effect of COMP vs TPD was found. Smokers' intentions to use an EC in a quit attempt next month were higher after exposure to the COMP vs. the TPD.

3. Results {#s0050}
==========

3.1. Demographics {#s0055}
-----------------

[Table 2](#t0010){ref-type="table"} summarises demographics and smoking characteristics. No differences were observed between conditions on key demographic characteristics (*p*s \> 0.05; See [supplementary materials](#s0130){ref-type="sec"} for exact test statistics and p values).Table 2Sample characteristics (N = 2495).N%MeanSDMinMaxSex**------------** Male117347**--------** Female132253**--------**Ethnicity**--------** White230392.3**--------** Black/African/Caribbean381.5**--------** Mixed/Multiple ethnic background441.8**--------** South Asian/Indian/Pakistani/Bang753.0**--------** Chinese/Other Asian background210.8**--------** Other140.5**--------**Occupation**--------** Routine and manual72329.0**--------** Intermediate47719.1**--------** Managerial & professional68427.4**--------** Never worked & Long term unemployed61124.5**--------**Highest qualification to date**--------** Degree (or equivalent)72929.2**--------** Higher education (below degree level)25910.4**--------** A-levels or Highers44517.8**--------** ONC or National level BTEC1516.1**--------** O-Level or GCSE equivalent (A-C)27716.5**--------** GCSE (D-E), CSE (2--5) or standard grade (4--6)11.1**--------** Other qualifications1004.0**--------** No formal qualifications1234.9**--------**Age segments**------------** 18--49139856**--------** 50+109744**--------**Smoking status**--------** Daily smokers115844.41**--------** Occasional smokers1255.01**--------** Non-smoker121248.6**--------**Past EC use**--------** Never used176870.9**--------** Past experimentation[1](#tblfn1){ref-type="table-fn"}30112.1**--------** Former occasional users[2](#tblfn2){ref-type="table-fn"}25310.1**--------** Former daily users1736.9**--------**Quit attempts (Smokers N = 1283) Yes86167.11**--------** No42232.89**--------**Number of past quit attempts (N = 1283)**----**3.875.371100Number of years smoking26.2314.950.864*FTCD*[3](#tblfn3){ref-type="table-fn"} (N = 1283)**----**4.082.48010*MTSS*[4](#tblfn4){ref-type="table-fn"} (N = 1283)**----**3.061.6917[^1][^2][^3][^4][^5]

TPD1 and 2 were combined in the analyses as scores of risk perceptions and intentions did not differ (ps \> 0.05), thus subsequent references to TPD are to both TPD messages combined. All confidences intervals reported are at 95%.

### 3.1.1. Perceptions of EC related to harms {#s0060}

ANCOVAs revealed a main effect of Smoking Status F(1, 2408) = 63.21, p \< .001, ƞ~p~^2^ = 0.03; Non-smokers perceived EC as more harmful compared to smokers (Smokers, M = 4.97 \[CI: 4.91--5.01\] vs. Non-smokers M = 5.28 \[CI: 5.22--5.33\]). There was also a main effect of TPD Presence F(1, 2408) = 31.89, p \< .001, ƞ~p~^2^ = 0.01. Harm-related perceptions were greater in those exposed to TPD (M = 5.23 \[CI: 5.19--5.27\]) compared to TPD absence conditions (M = 5.01 \[CI: 4.95--5.07\]). After adjusting for Motivation to Quit and Cigarette Dependence, a main effect of COMP was shown F(1, 1238) = 7.11, p = .008, ƞ~p~^2^ = 0.006. Following exposure of the COMP message, smokers perceived EC as less harmful compared to exposure to other messages. A-priori comparisons revealed that both smokers and non-smokers exposed to the TPD perceived EC as significantly more harmful compared to those exposed to the COMP alone (see [Table 3](#t0015){ref-type="table"}). In non-smokers only, exposure to the TPD alone showed increased harm perceptions compared to *No message*. In both smokers and non-smokers, significantly lower scores were shown following exposure to the COMP alone message compared to the TPD alone and the TPD + COMP combined. However, in smokers only, exposure to the COMP alone led to reduced harm perceptions compared to *No message* (see [Table 3](#t0015){ref-type="table"}). A significant Smoking status by COMP presence interaction was shown, F(1, 2408) = 6.325, p = .012, ƞ~p~^2^ = 0.003; Simple effects revealed that smokers' perceptions differed significantly when COMP was present (M = 4.89 \[CI: 4.81--4.92\]) compared to when it was absent (M = 5. 05 \[CI: 4.97--5.12\]). Non-smokers' harm perceptions were higher than that of smokers; when COMP was present (M = 5.29 \[CI: 5.21--5.37\]) harm perceptions were slightly higher compared to when COMP was absent (M = 5.26 \[CI: 5.18--5.33\]).Table 3Means \[95% CI\] perceptions related to EC per smoking status with TPD alone vs. COMP alone vs. TPD + COMP vs. *No message*.SmokersNon-smokersNM \[95%CI\]A-prioripNM \[95%CI\]A-priorip**PerceptionsHarm**12451 vs. 20.08511721 vs. 20.3531. TPD alone4.89 \[4.80--4.98\]1 vs. 30.0965.66 \[5.59--5.74\]1 vs. 3[\*](#tblfn5){ref-type="table-fn"}0.0012. TPD + COMP4.78 \[4.69--4.87\]1 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0015.61 \[5.54--5.69\]1 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0023. *No message*4.76 \[4.63--4.89\]2 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0075.33 \[5.22--5.44\]2 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0194. COMP alone4.55 \[4.41--4.69\]3 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0345.45 \[5.33--5.56\]3 vs. 40.150**Addictiveness**12381 vs. 20.10911711 vs. 20.2541. TPD alone5.18 \[5.11--5.16\]1 vs. 3[\*](#tblfn5){ref-type="table-fn"}0.0126.02 \[5.94--6.09\]1 vs. 3[\*](#tblfn5){ref-type="table-fn"}0.0012. TPD + COMP5.28 \[5.20--5.36\]1 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0075.96 \[5.88--6.03\]1 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0013. *No message*5.00 \[4.89--5.12\]2 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0015.64 \[5.54--5.75\]2 vs. 4[\*](#tblfn5){ref-type="table-fn"}0.0014. COMP alone4.98 \[5.86--5.11\]3 vs. 40.7875.66 \[5.55--5.77\]3 vs.40.834**Effectiveness**12681 vs. 20.37612121 vs. 20.8661. TPD alone4.36 \[4.26--4.46\]1 vs. 30.3354.14 \[4.04--4.23\]1 vs. 30.3872. TPD + COMP4.43 \[4.33--4.53\]1 vs. 40.4124.12 \[4.03--4.22\]1 vs. 40.3433. *No message*4.28 \[4.13--4.42\]2 vs. 40.8984.21 \[4.08--4.34\]2 vs. 40.2784. COMP alone4.44 \[4.29--4.59\]3 vs. 40.1284.22 \[4.08--4.36\]3 vs. 40.922**Social acceptability**12441 vs. 20.89212121 vs. 20.6211. TPD alone4.75 \[4.67--4.84\]1 vs. 30.5793.87 \[3.77--3.96\]1 vs. 30.8472. TPD + COMP4.75 \[4.66--4.83\]1 vs. 40.3433.83 \[3.74--3.92\]1 vs. 40.6903. *No message*4.71 \[4.59--4.84\]2 vs. 40.3993.85 \[3.72--3.98\]2 vs. 40.9894. COMP alone4.68 \[4.55--4.81\]3 vs. 40.7273.83 \[3.69--3.97\]3 vs. 40.854[^6][^7]

### 3.1.2. Perceptions of EC related to addictiveness {#s0065}

There was a main effect of Smoking Status F(1, 2400) = 68.55, p \< .001, ƞ~p~^2^ = 0.03; Smokers perceived EC as less addictive than non-smokers (Smokers, M = 5.31 \[CI: 5.26--5.36\] vs. non-smokers M = 5.61 \[CI: 5.56--5.66\]). There was a main effect of TPD presence F(1, 2400) = 65.31, p \< .001, ƞ~p~^2^ = 0.03; significantly increased scores were shown for those who had been exposed to the TPD compared to no presence conditions (TPD present M = 5.60 \[CI: 5.56--5.64\] vs. TPD absent M = 5.32 \[CI: 4.95--5.07\]). A-priori comparisons revealed that compared to the COMP alone and *No message* conditions, exposure to the TPD increased perceptions of addictiveness. In addition, exposure to the COMP alone compared to both the TPD and the COMP combined (TPD + COMP) led to significantly lower perceptions of addictiveness in both smokers and non-smokers (see [Table 3](#t0015){ref-type="table"}).

### 3.1.3. Perceptions of EC related to their effectiveness {#s0070}

No significant main effects, interaction nor a-priori contrasts were identified (*p*s \> 0.05) (see [Table 3](#t0015){ref-type="table"}).

### 3.1.4. Perceptions of social acceptability of EC {#s0075}

There was a main effect of Smoking Status, F(1, 2447) = 11.01, p \< .001, ƞ~p~^2^ = 0.004; Smokers (M = 4.36 \[CI: 4.30--4.41\]) perceived EC to be more socially acceptable compared to non-smokers (M = 4.22 \[CI: 4.16--4.28\]). All remaining main effect, interaction and a-priori comparisons were not significant (ps \> 0.05) (see [Table 3](#t0015){ref-type="table"}).

### 3.1.5. Intentions to purchase an EC next month and in 6 months {#s0080}

In the next month and in 6 months respectively, ANCOVAs revealed a main effect of Smoking Status F(1, 2416) = 42.46, p \< .001, ƞ~p~^2^ = 0.02 and F(1, 2417) = 55.47, p \< .001, ƞ~p~^2^ = 0.02. Smokers reported higher intentions to purchase an EC compared to non-smokers (Smokers M = 1.93 \[CI: 1.88--1.98\] vs. non-smokers M = 1.66 \[CI: 1.60--1.72\]) and in the next 6 months respectively (Smokers M = 2.04 \[CI: 1.98--2.09\] vs. non-smokers M = 1.73 \[CI: 1.67--1.79\]). A-priori comparisons revealed higher purchase intentions in those exposed to the COMP alone compared to the TPD alone in smokers only (see [Table 4](#t0020){ref-type="table"}). All remaining main and interaction effects were not significant (ps \> 0.05).Table 4Means \[95% CI\] Intentions per smoking status with TPD alone vs. COMP alone vs. TPD + COMP vs. *No message*.SmokersNon-smokersNM \[95%CI\]A-prioripNM \[95%CI\]A-priorip**IntentionsEC Purchase next month**12831 vs. 20.60011331 vs. 20.8851. TPD alone2.44 \[2.33--2.55\]1 vs. 30.8401.01 \[1.00--1.02\]1 vs. 30.9272. TPD + COMP2.48 \[2.37--2.59\]1 vs. 4[\*](#tblfn6){ref-type="table-fn"}0.0491.01 \[1.00--1.02\]1 vs. 40.4923. *No message*2.46 \[2.30--2.62\]2 vs. 40.1191.01 \[1.00--1.02\]2 vs. 40.5624. COMP alone2.64 \[2.47--2.80\]3 vs. 40.1261.00 \[0.99--1.02\]3 vs. 40.500**EC Purchase in 6 months**12831 vs. 20.44511341 vs. 20.4931. TPD alone2.63 \[2.53--2.74\]1 vs. 30.6101.01 \[1.01--1.02\]1 vs. 30.8222. TPD + COMP2.69 \[2.58--2.80\]1 vs. 40.5821.01 \[1.00--1.02\]1 vs. 40.3783. *No message*2.68 \[2.53--2.83\]2 vs. 40.9651.01 \[1.00--1.02\]2 vs. 40.7224. COMP alone2.68 \[2.53--2.85\]3 vs. 40.9621.01 \[0.99--1.02\]3 vs. 40.564**EC Use next month**12831 vs. 20.50011301 vs. 20.6551. TPD alone2.52 \[2.41--2.62\]1 vs. 30.9731.01 \[1.00--1.02\]1 vs. 30.1112. TPD + COMP2.57 \[2.46--2.68\]1 vs. 40.1441.01 \[1.00--1.01\]1 vs. 40.6963. *No message*2.52 \[2.37--2.68\]2 vs. 40.3501.02 \[1.01--1.03\]2 vs. 40.9644. COMP alone2.66 \[2.50--2.82\]3 vs. 40.2181.00 \[0.99--1.02\]3 vs. 40.092**EC Use in 6 months**12831 vs. 20.84311301 vs. 20.4161. TPD alone2.72 \[2.61--2.82\]1 vs. 30.7871.01 \[1.00--1.02\]1 vs. 30.6992. TPD + COMP2.73 \[2.62--2.84\]1 vs. 40.2221.01 \[1.00--1.02\]1 vs. 40.8643. *No message*2.74 \[2.59--2.90\]2 vs. 40.2861.02 \[1.00--1.03\]2 vs. 40.4194. COMP alone2.84 \[2.68--3.00\]3 vs. 40.4071.01 \[1.00--1.03\]3 vs. 40.858[^8][^9]

### 3.1.6. Intentions to use an EC next month and in 6 months {#s0085}

A main effect of smoking status was shown only after adjusting for EC past exposure, F(1, 2403) = 42.06, p \< .001, ƞ~p~^2^ = 0.02. Smokers reported higher intentions to use an EC compared to non-smokers (Smokers M = 1.97 \[CI: 1.92--2.02\] vs. non-smokers M = 1.70 \[CI: 1.63--1.75\]). All remaining main and interaction effects were not significant (ps \> 0.05).

### 3.1.7. Smokers' intentions to quit and use EC in future quit attempts {#s0090}

For intentions to quit in the next month, ANCOVAs revealed a main effect of TPD Presence F(1,1278) = 5.26, p = .022, ƞ~p~^2^ = 0.004; When present, smokers' intentions to quit were lower (M = 2.63 \[CI: 2.57--2.70\]) compared to when TPD was absent (M = 2.77 \[CI: 2.67--2.87\]). There was no main effect of COMP presence (COMP present M = 2.74 \[CI: 2.65--2.82\] vs. COMP absent M = 2.67 \[CI: 2.58--2.75\]; p = .248). There was no significant interaction (p = .201). A-priori comparisons revealed that smokers reported increased intentions to quit in the next month when showed the COMP alone. The COMP message significantly differed from exposure to the TPD and exposure to both messages combined (TPD + COMP) ([Table 5](#t0025){ref-type="table"}).Table 5Means \[CI\] Smokers' intentions with TPD alone vs. COMP alone vs. TPD + COMP vs. *No message*.NM \[95%CI\]A-priorip**Intentions (Smokers only)Quit next month**12831 vs. 20.9111. TPD alone2.64 \[2.54--2.73\]1 vs. 30.4672. TPD + COMP2.63 \[2.53--2.72\]1 vs. 4\*0.0163. *No message*2.70 \[2.56--2.84\]2 vs. 4\*0.0134. COMP alone2.85 \[2.70--3.00\]3 vs. 40.142**Quit in 6 months**12831 vs. 20.8621. TPD alone3.13 \[3.04--3.23\]1 vs. 30.9892. TPD + COMP3.12 \[3.03--3.22\]1 vs. 40.1203. *No message*3.13 \[3.00--3.27\]2 vs. 40.0914. COMP alone3.27 \[3.13--3.41\]3 vs. 40.175**EC Use in quit attempt next month**7321 vs. 20.3171. TPD alone1.16 \[1.06--1.25\]1 vs. 30.8672. TPD + COMP1.22 \[1.13--1.31\]1 vs. 40.2163. *No message*1.17 \[1.04--1.30\]2 vs. 40.6394. COMP alone1.26 \[1.12--1.40\]3 vs. 40.343**EC Use in quit attempt in 6 months**6351 vs. 20.2941. TPD alone1.18 \[1.08--1.29\]1 vs. 30.9782. TPD + COMP1.26 \[1.16--1.36\]1 vs. 40.3123. *No message*1.18 \[1.04--1.33\]2 vs. 40.8404. COMP alone1.28 \[1.12--1.44\]3 vs. 40.385[^10]

For intentions to quit within 6 months, and intentions to use an EC in a quit attempt in the next month and in the next 6 months, no significant differences between conditions was shown (ps \< 0.05).

4. Discussion {#s0095}
=============

This study compared the effects of the EU-TPD EC nicotine addiction health warning to a comparative harm (COMP) message on smokers' and non-smokers' perceptions of EC. We also examined the effects of these messages on purchase intentions, and on smokers' intentions to quit and to use an EC in a quit attempt. The potential effects of a comparative risk message either in addition to the TPD warnings or as a stand-alone message were also explored.

Smokers perceived EC as less harmful, less addictive and more socially acceptable than non-smokers. EC were perceived as more harmful following exposure to the TPD messages by both smokers and non-smokers. Following exposure to the COMP alone EC were perceived as less harmful by both smokers and non-smokers when compared to both messages combined. However, when compared with no message, reduction in perceptions of EC harm was shown after exposure to the COMP alone only in smokers. This suggests that adding the COMP as a stand-alone message to EC packs, may reduce smokers' harm perceptions of EC whilst leaving non-smokers' EC harm perceptions unaffected. For perceptions of EC addictiveness, the TPD and the COMP alone conditions differed significantly. Perceptions of EC addictiveness increased in both smokers and non-smokers following exposure to the TPD relative to those exposed to no messages and those exposed to the COMP. Similarly, smokers and non-smokers exposed to the COMP alone perceived EC as less addictive compared to those exposed to both the TPD and COMP messages combined. For EC purchase intentions smokers reported increased intentions to buy in the next month (although not in the next 6 months) compared to non-smokers. Critically, in smokers (not non-smokers), exposure to the COMP message increased intentions to purchase an EC in the next month compared to exposure to the TPD messages; this was the case only when the COMP message was presented alone. The COMP message led to higher quit intentions compared to the TPD in smokers only.

That non-smokers were more likely to endorse beliefs about EC addictiveness and harm compared to smokers corroborates previous evidence ([@b0110], [@b0135], [@b0180]). It is unsurprising that non-smokers were more likely to be influenced by a health warning such as the TPD because it is likely to align with their pre-existing tobacco and nicotine beliefs.

The finding that perceptions of harm differed between smokers and non-smokers following exposure to the COMP message alone compared to no messages suggests that smokers may be more receptive to the COMP than non-smokers. This is encouraging to the extent that reduced harm messages which convey relative risks and encourage a switch away from smoking is important for smokers, but at the same time should not encourage use among non-smokers. In other words, it suggests specificity for better targeting these individuals by increasing engagement about the relative risks of EC. However, when comparing the TPD messages to no message, the increase in harm perceptions was only present for non-smokers. To some extent, this demonstrates the effectiveness of the TPD messages as a smoking prevention tool without also increasing harm perceptions among smokers.

Exposure to the COMP alone was also associated with reduced scores on perceptions of addictiveness of EC compared to the TPD and the TPD + COMP. Thus, COMP may act as a stand-alone message as opposed to as an adjunct to the TPD. Previous work which paired relative risks health statements with addiction warnings has failed to show any influence on addictiveness perceptions and use intentions ([@b0170]). Given this study also found a reduction in credibility and believability of the message ([@b0170]), one possible explanation for this loss in credibility could be attributed to the pairing of a reduced risk statement and a warning label (warning against harm) which is likely to be perceived as conflicting and ambiguous, leading to message rejection ([@b0080]). Another likely factor to have influenced our findings could be that the warning message preceding the reduced risk (TPD + COMP), it is unclear whether a different ordering would have yielded different outcomes. An alternative explanation for the TPD to exert such influence even when accompanied by the COMP is that perceptions may have been influenced by increasing familiarity (via past repeated exposure to the TPD). Moreover, because public perceptions of nicotine's addictiveness and harmfulness are likely to be an established belief set available for processing (e.g. [@b0005], [@b0035], [@b0100], [@b0145], [@b0180]), it is likely that individuals will bring such grounded beliefs when interacting with any message. Thus, participants may be processing messages based on more belief-based heuristics.

The TPDs and the COMP messages did not differ in their influence on perceptions of EC as effective stop smoking aids nor did they affect perceptions on social acceptability, perhaps because none focus on effectiveness or social acceptability. Because such a focus may influence switching amongst smokers, they may require separate attention from messages focusing on harm.

As expected, the COMP led to higher purchase intentions compared to the TPD in smokers only, but these effects were lost when participants were asked to rate their intentions over 6 months. There were no effects or differences in intentions to use EC in the future and overall ratings were low. Although previous studies ([@b0015], [@b0025], [@b0095], [@b0105]), found that the TPD have the potential to deter smokers from substituting their tobacco for EC use, here, exposure to the TPD only, did not reduce smokers' use intentions compared to no message. Thus, while COMP versus TPD may be more favourable towards encouraging harm reduction for smokers, TPD only versus no TPD may not necessarily discourage harm reduction for smokers. Exposure to the COMP alone led to greater quit intentions compared to the TPD and both messages combined (TPD + COMP). Thus, in this study, we demonstrate that presenting a message that conveys the relative risks of EC to smoking, can increase EC purchase and quit intentions in smokers.

Ideally, a comparative harm message would reduce perceptions of harm in both smokers and non-smokers, while increasing intentions to use for smokers. However, we found that although the COMP showed lower harm and addictiveness perceptions of EC in both smokers and non-smokers, the COMP alone against no message did not affect non-smokers' perceptions whilst increasing purchase intentions in smokers only. Furthermore, the null effects of COMP on use intentions in non-smokers is a promising finding in that it suggests such exposure might not result in unintended effects.

4.1. Limitations {#s0100}
----------------

The study has several limitations. Although the sample was matched to the ONS data to represent the smoking population, it was self-selecting, potentially introducing response bias. Secondly, whilst findings of this study are informative and help further our understanding of communication of risks related to EC, these are confined to intentions. Prospective studies could focus on exploring how to translate intentions into behaviours.

5. Conclusions {#s0105}
==============

The findings suggest that messages such as the COMP can help redress harm perceptions associated with EC and encourage smokers to switch to EC. When communicating health risks, it is important that messages are clear and unambiguous. Any future communication strategy to include a comparative message, such as the one developed here, has greater potential to impact as a stand-alone message.
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[^1]: Note.

[^2]: Past experimentation = Used an EC very rarely in the past and no longer use it.

[^3]: Former occasional users = Used an EC occasionally (not daily) in the past and no longer use it.

[^4]: FTCD = Fagerström Test for Cigarette Dependence.

[^5]: MTSS = Motivation to Stop \[Smoking\] Scale; FTCD and MTSS both were measured in smokers only.

[^6]: Note.

[^7]: Significant differences were accepted at level p ≤ 0.05 using Univariate a-priori comparisons and estimated marginal means with 95% confidence intervals; A-priori comparisons are: Level 1 vs. 2 = TPD alone vs. TPD + COMP; Level 1 vs. 3 = TPD alone vs. *No message*; Level 1 vs. 4 = TPD alone vs. COMP alone; Level 2 vs. 4 = TPD + COMP vs. COMP alone; Level 3 vs. 4 = *No message* vs. COMP alone.

[^8]: Note. All intentions were measured on a 7-point rating scales with the anchors "Extremely likely to Not at all likely to" scoring from 7 to 1.

[^9]: Significant differences were accepted at level p ≤ 0.05 using Univariate a-priori comparisons and estimated marginal means with 95% confidence intervals; A-priori comparisons are Level 1 vs. 2 = TPD alone vs. TPD + COMP; Level 1 vs. 3 = TPD alone vs. *No message*; Level 1 vs. 4 = TPD alone vs. COMP alone; Level 2 vs. 4 = TPD + COMP vs. COMP alone; Level 3 vs. 4 = *No message* vs. COMP alone.

[^10]: Note. All intentions were measured on a 7-point rating scales with the anchors "Extremely likely to Not at all likely" scoring from 7 to 1; \* Significant differences were accepted at level p ≤ 0.05 using a-priori comparisons and estimated marginal means with 95% confidence intervals; A-priori comparisons are: Level 1 vs. 2 = TPD alone vs. TPD + COMP; Level 1 vs. 3 = TPD alone vs. *No message*; Level 1 vs. 4 = TPD alone vs. COMP alone; Level 2 vs. 4 = TPD + COMP vs. COMP alone; Level 3 vs. 4 = *No message* vs. COMP alone.
